Vertex Pharmaceuticals Financial Overview
Vertex Pharmaceuticals's market cap is currently $115.75B. The company's EPS TTM is $4.8; its P/E ratio is 32.15; Vertex Pharmaceuticals is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $5.12. See an overview of income statement, balance sheet, and cash flow financials.
